Navigation Links
Indication of considerable added benefit of vemurafenib in advanced melanoma
Date:1/8/2013

The drug vemurafenib (trade name Zelboraf) has been approved since February 2012 for the treatment of advanced melanoma (cancer of the skin cells that produce the dark pigment, melanin). It can be an option for adults whose melanoma cannot be removed by surgery or has formed secondaries (metastases) and in whose cancer a change (mutation) has occurred in a certain gene (BRAF-V600). The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG). According to the findings, major advantages in terms of overall survival are accompanied by major potential harm in the form of side effects. Overall, there is an indication that vemurafenib offers considerable added benefit.

Vemurafenib in comparison with dacarbazine

The Federal Joint Committee (G-BA) has specified the drug dacarbazine as the appropriate comparator therapy. One study that compared vemurafenib directly with dacarbazine was available for the benefit assessment. This is a randomized and open-label study, i.e. patients were randomly assigned to one of the two treatment groups and both they and their doctors knew which of the two drugs was used in each case.

Longer survival means major added benefit

IQWiG always assesses a drug with a view to patient-relevant outcomes such as survival (mortality), symptoms and complications (morbidity) as well as quality of life. The study provides an indication that vemurafenib can prolong life. While half of the patients who received dacarbazine died after less than 10 months, in the vemurafenib group this was the case only after more than 13 months. The differing course of the two survival curves provides an indication of a major added benefit of vemurafenib.

Pain was the only outcome recorded in the study in relation to morbidity. There were, however, no statistically significant diff
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
0049-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Antibody-coated stents: Indication of disadvantages
2. Abiraterone: Indication of considerable added benefit in certain patients
3. Considerable added benefit of ipilimumab in advanced melanoma
4. Marketing Xocolate International Corporation (MXI-Corp) Introduces Xe Healthy Energy Drink, A Rich And Delicious Antioxidant Beverage, Now Added to Xoçai™ Product Line
5. Capsiplex Plus Reviews for Improved Weight Loss Supplement Added to BestAppetiteSuppressantPills.com
6. UV-Aid Cold and Flu Prevention Added to List of Biomimicry Strategies on AskNature.Org
7. Healthy Chocolate Omega Squares, a Decedent Dark Chocolate Added to Marketing Xocolate International Corporation (MXI Corp) Product Lines
8. Rilpivirine for HIV: Added benefit for single agent proven
9. US Drug Watchdog Has Added Wright, Stryker, Biomet, and Zimmer To Their Initiative For All Metal Hip Implant Failures Victims & Offers Them The Names Of The Best Lawyers
10. CFO 911 Solutions' Charles K. Dargan II, CEO, and Reid Dabney, Managing Director Have Been Added to the Financial Entrepreneur Platform ("FEP") of Merriman Capital, Inc., a Wholly Owned Subsidiary of Merriman Holdings, Inc. (OTCQX: MERR)
11. Vandetanib in thyroid cancer: No proof of added benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The market for botulinum ... few years, owing to novel medical indications created and ... the aging societies where physical appearance is extremely valued. ... player, current competitors, new companies and technologies are setting ... BoNTs will put the price of 1st-gen products under ...
(Date:7/22/2014)... July 22, 2014 CarePoint Health is pleased ... as the President of the medical staff at Bayonne Medical ... serve as President, as voted on by the physicians on ... medical staff in relation to the administration at Bayonne Medical ... physicians and to work to make the Medical Center the ...
(Date:7/22/2014)... The Middle East Drilling fluid and Completion ... completion fluid market in Middle East with analysis and forecast ... Middle East is estimated to grow from around $560 million ... of 5.7%, for the given period. , Browse through the ... Market report, to get an idea of the in-depth analysis ...
(Date:7/22/2014)... 22, 2014 Over the years, ... every sphere of human anatomy. In the pursuit, ... that rendered the possibility of deploying certain tests ... and tissues, in order to detect the presence ... Essentially, In-vitro Diagnostics (IVD) have earned the title ...
(Date:7/22/2014)... time? How can women meet the demands of a ... become a mother has a profound effect on the ... the physical sciences. Yet many women successfully manage to ... Professor, fifteen inspirational personal accounts describe the challenges and ... chemistry. , The authors of the contributions are all ...
Breaking Medicine News(10 mins):Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4
... 4 Over 100 million Americans,are plagued by high cholesterol, ... the Healthy Monday campaign suggests Americans take the,idea of Fat ... from,meat-heavy, high-fat diets., "Carnival" has its roots in the ... Eating a little less meat can be a big,step towards ...
... Deal follows positive phase I data from novel product ... the ... 4 Amira Pharmaceuticals and,GlaxoSmithKline today announced they have ... commercialize FLAP,(5-Lipoxygenase Activating Protein ) inhibitors for the treatment ...
... 4 The Providence Service,Corporation (Nasdaq: PRSC ... Executive Officer, is scheduled to present an overview ... Services Conference on,Monday, February 11, 2008 at the ... presentation is scheduled for 12:00 p.m. EST. The,presentation ...
... using shampoo, lotion and powder, study shows , , MONDAY, Feb. ... tested in a new study had been exposed to a ... what this means in terms of infant health isn,t yet ... to be harmful to development, and one study on human ...
... Triple-S,Management Corporation (NYSE: GTS ) today announced that ... Roman,Finance Vice President and Chief Financial Officer, will present ... Conference in,New York City on February 12, 2008, at ... through the Internet and will remain,archived for 90 days. ...
... -, PALO ALTO, Calif., Feb. 4 PEAK ... new category of tissue,dissection systems based on a proprietary ... a Series C financing led by new investor,Signet Healthcare ... of Signet Healthcare Associates, has joined PEAK,Surgical,s board of ...
Cached Medicine News:Health News:Mardi Gras Means Lean Times Ahead But That Doesn't Mean the Party's Over 2Health News:Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 2Health News:Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 3Health News:Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program 4Health News:Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11 2Health News:Many Babies Exposed to Chemicals 2Health News:Many Babies Exposed to Chemicals 3Health News:PEAK Surgical, Inc. Closes $21 Million Series C Financing 2
(Date:7/22/2014)... , July 22, 2014 The number of ... 45 people each day. Twenty-three percent of the workforce ... on Drug Use and Health, making opioid use a ... taking opioid painkillers at the correct dosage with a ... Today, the National Safety Council released ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... , July 22, 2014 Elekta (NSE:EKTAb) and ... that The Christie NHS Foundation Trust ( Manchester, ... a consortium whose mission is to develop the clinical ... radiation therapy system. Such a system would, in principle, ... cancer targets. "The Christie was an ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... 1 Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: ... a quarterly royalty payment of approximately $1.5 million ... Memantine for the treatment of Alzheimer,s disease. Under ... royalty payments on certain sales of Memantine by ...
... Inc. (OTC Bulletin Board: SCIE) , a San Diego based ... an article reporting that its LUMA cervical imaging system is enhancing ... . Since Last July, researchers at the University ... LUMA Cervical Imaging System in more than 80 women - in ...
Cached Medicine Technology:Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams 2Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams 3
UST-675-P is our end-fire prostate transducer. Multiple frequencies provide extraordinary imaging capabilities for your diverse patient population, and the biopsy guide enables accurate and fast pros...
Super High Density 360 degree radial rectal transducer. High resolution in the near field and lower frequencies for deeper penetration make this transducer the optimal choice when scanning the anal c...
Our most versatile transducer for superficial imaging. Wide Band, Super High Density, multi-frequency transducer with superb Doppler and color flow sensitivity make this an excellent choice for breas...
... 5545 linear transducer is our high ... superficial and vascular imaging. Multiple frequencies ... sensitivity combined with our exclusive transducer ... PixelFocus to provide excellent resolution and ...
Medicine Products: